原发性扩张型心肌病左心室逆重构的预测因素

宗敏, 关晓楠, 张建军. 原发性扩张型心肌病左心室逆重构的预测因素[J]. 临床心血管病杂志, 2021, 37(9): 846-849. doi: 10.13201/j.issn.1001-1439.2021.09.013
引用本文: 宗敏, 关晓楠, 张建军. 原发性扩张型心肌病左心室逆重构的预测因素[J]. 临床心血管病杂志, 2021, 37(9): 846-849. doi: 10.13201/j.issn.1001-1439.2021.09.013
ZONG Min, GUAN Xiaonan, ZHANG Jianjun. Predictors of left ventricular reverse remodeling in dilated cardiomyopathy[J]. J Clin Cardiol, 2021, 37(9): 846-849. doi: 10.13201/j.issn.1001-1439.2021.09.013
Citation: ZONG Min, GUAN Xiaonan, ZHANG Jianjun. Predictors of left ventricular reverse remodeling in dilated cardiomyopathy[J]. J Clin Cardiol, 2021, 37(9): 846-849. doi: 10.13201/j.issn.1001-1439.2021.09.013

原发性扩张型心肌病左心室逆重构的预测因素

详细信息
    通讯作者: 张建军,E-mail:zmn0359@vip.sina.com
  • 中图分类号: R542.2

Predictors of left ventricular reverse remodeling in dilated cardiomyopathy

More Information
  • 目的:探讨原发性扩张型心肌病(DCM)出现左心室逆重构(LVRR)的影响因素。方法:顺序入选2011年1月—2017年10月于首都医科大学附属北京朝阳医院心内科首次住院的原发性DCM患者,其中左心室射血分数(LVEF)<40%的患者纳入研究,随访时间2年。以首次住院超声心动图LVEF为基础,以末次复查时LVEF≥40%且较基线值增加10%以上为LVRR组,其余患者为NLVRR组。通过调取住院及门诊资料,采取门诊面访、电话随访等方式,分析患者的临床生化资料及心脏超声结果。对有统计学意义的临床资料进一步行多因素Logistic分析,探讨影响LVRR的预测因素。结果:研究共纳入符合条件的原发型DCM患者70例,其中出现LVRR的患者45例,LVRR发生率64%,LVRR组的BMI值、LVEF值、血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂使用率高于NLVRR组,左束支传导阻滞(LBBB)比例、心率、出院N末端利钠肽前体值、病程、左室舒张末期内径(LVEDD)值低于NLVRR组(P<0.05)。对有统计学差异的因素进一步行多因素Logistic回归分析,影响LVRR的独立预测因素为DCM家族史(OR=0.041,95%CI 0.003~0.53,P=0.014)、LBBB(OR=0.123,95%CI 0.026~0.588,P=0.011)、LVEDD<65 mm(OR=10.058,95%CI 1.067~32.420,P=0.044)、LVEF≥35%(OR=6.612,95%CI 1.349~0.53,P=0.020),对上述4个独立预测因子进行联合因子受试者特征工作曲线分析并计算其曲线下面积(AUC),联合因子预测LVRR的敏感性为82.22%,特异性为92%,AUC为0.920。结论:DCM家族史、LBBB、LVEF≥35%及LVEDD<65 mm为原发型DCM患者LVRR的独立预测因素,联合因子对预测LVRR有较好的敏感性及特异性。
  • 加载中
  • [1]

    中华医学会心血管病学分会心力衰竭学组.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):1001-1010.

    [2]

    Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC).Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur J Heart Fail,2016,18(8):891-975.

    [3]

    牛保松,慕春言,赵玉兰,等,特发性扩张型心肌病患者左心室逆重构的发生率、预测因素和预后分析[J].中国心血管杂志,2020,20(1):40-44.

    [4]

    Xu Y,Lin J,Liang Y,et al.Prognostic value of left ventricular remodelling index in idiopathic dilated cardiomyopathy[J].Eur Heart J Cardiovasc Imaging,2020,2020:111.

    [5]

    张健,邹长虹,黄燕,等.新发扩张型心肌病患者药物治疗后左心室逆重构的发生率及预测因素[J].中华心血管病杂志,2016,44(4):315-320.

    [6]

    中华医学会心血管病学分会.心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):111-120.

    [7]

    Matsumura Y,Hoshikawa-Nagai E,Kubo T,et al.Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy[J].Cardiovascular Ultrasound,2015,13:114.

    [8]

    Marume K,Noguchi T,Tateishi E,et al.Prognosis and clinical characteristics of dilated cardiomyopathy with family history via pedigree analysis[J].Circ J,2020,84(8):1284-1293.

    [9]

    McNamara DM,Holubkov R,Starling RC,et al.Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy[J].Circulation,2001,103(18):2254-2259.

    [10]

    邵夏炎,刘洪智,杨贝贝,等.沙库巴曲缬沙坦在心力衰竭患者中的用药策略[J].临床心血管病杂志,2020,36(3):240-245.

    [11]

    杨萍,丁澍,刘培晶,等.血管紧张素受体脑啡肽酶抑制剂治疗伴射血分数降低的心力衰竭的安全性和有效性观察[J].临床心血管病杂志,2020,36(3):250-254.

    [12]

    Abboud A,Januzzi JL.Reverse cardiac remodeling and ARNI therapy[J].Curr Heart Fail Rep,2021,18(2):71-83.

    [13]

    Russo V,Bottino R,Rago A,et al.The effect of sacubitril/valsartan on device detected arrhythmias and electrical parameters among dilated cardiomyopathy patients with reduced ejection fraction and implantable cardioverter defibrillator[J].J Clin Med,2020,9(4):111.

    [14]

    赵跃华,孟小敏,李向欣,等.心力衰竭诊断与药物治疗的研究进展[J].临床心血管病杂志,2020,36(4):382-386.

    [15]

    林雪,戴晓艳,陈未,等.规范药物治疗的射血分数重度减低的扩张型心肌病患者长期预后的影响因素分析[J].中国心血管杂志,2020,25(2):110.

    [16]

    Mandawat A,Chattranukulchai P,Mandawat A,et al.Progression of Myocardial Fibrosis in Nonischemic DCM and Association with Mortality and Heart Failure Outcomes,JACC Cardiovasc Imaging(2021).

    [17]

    Tayal U,Wage R,Newsome S,et al.Predictors of left ventricular remodelling in patients with dilated cardiomyopathy-a cardiovascular magnetic resonance study[J].Euro J Heart Fail,2020,22(7):1160-1170.

    [18]

    Sze E,Dunning A,Loring Z,et al.Comparison of incidence of left ventricular systolic dysfunction among patients with left bundle branch block versus those with normal QRS duration[J].Am J Cardiol,2017,120(11):1990-1997.

    [19]

    Riedlbauchová L,Adla T,Suchánek V,et al.Is left bundle branch block pattern on the ECG caused by variable ventricular activation sequence?[J].Pacing Clin Electrophysiol,2020,43(5):486-494.

    [20]

    Sze E,Samad Z,Dunning A,et al.Impaired recovery of left ventricular function in patients with cardiomyopathy and left bundle branch block[J].J Am Coll Cardiol,2018,71(3):306-317.

    [21]

    Kimura Y,Okumura T,Morimoto R,et al.A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy[J].ESC Heart Fail,2021,10:110.

    [22]

    Jung IH,Park JH,Lee JA,et al.Left ventricular global longitudinal strain as a predictor for left ventricular reverse remodeling in dilated cardiomyopathy[J].J Cardiovasc Imaging,2020,28(2):137-149.

  • 加载中
计量
  • 文章访问数:  446
  • PDF下载数:  174
  • 施引文献:  0
出版历程
收稿日期:  2021-03-11

目录